Mutational analyses ofBRCA1 andBRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancerRonit Shiri‐Sverdlov, Eitan Friedman, Shulamit Rizel et al.|Human Mutation|2000Cited by 53
An identical novel mutation in BRCA1 and a common haplotype in familial ovarian cancer in non-Ashkenazi JewsLivia Theodor, Eitan Friedman, Revital Bruchim Bar-Sade et al.|British Journal of Cancer|1998Cited by 9
Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancerRonit Shiri‐Sverdlov, Eitan Friedman, Peter J. Oefner et al.|Human Mutation|2000Cited by 4
Cognitive Impairment in Nonagenarians: Potential Metabolic Mechanisms Revealed by the Synergy of In Silico Gene Expression Modeling and Pathway Enrichment AnalysisА. А. Мамчур, S. M. Yudin, Еlena Zelenova et al.|International Journal of Molecular Sciences|2024Cited by 4
[Experience at Sheba Hospital in oncogenetic counseling and genetic testing of women with a high risk for breast and ovarian cancer].Livia Theodor, Eitan Friedman, Ronit Shiri‐Sverdlov et al.|PubMed|1998Cited by 1